Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umender Sharma

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Discovery|June 1, 2012
Current possibilities and unresolved issues of drug target validation in Mycobacterium tuberculosisUmender Sharma
Drug Discovery Today|January 13, 2018
Phage-derived lysins as potential agents for eradicating biofilms and persistersUmender Sharma, Aradhana Vipra, Shankaramurthy Channabasappa
Critical Care (London, England)|May 5, 2017
Bacteriophage lysins as antibacterialsUmender Sharma, Vivek D Paul
Microbiology (Reading, England)|November 15, 2011
Alanine racemase mutants of Mycobacterium tuberculosis require D-alanine for growth and are defective for survival in macrophages and miceDisha Awasthy, Sowmya Bharath, Venkita Subbulakshmi, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2016
Antibiofilm Activity and Synergistic Inhibition of Staphylococcus aureus Biofilms by Bactericidal Protein P128 in Combination with AntibioticsSandhya Nair, Srividya Desai, Nethravathi Poonacha, et al.
Gene|August 17, 2014
Roles of the two type II NADH dehydrogenases in the survival of Mycobacterium tuberculosis in vitroDisha Awasthy, Anisha Ambady, Ashwini Narayana, et al.
Gene|December 3, 2014
Revisiting the essentiality of glutamate racemase in Mycobacterium tuberculosisSapna Morayya, Disha Awasthy, Reena Yadav, et al.
Antimicrobial Agents and Chemotherapy|October 6, 2010
Rv1218c, an ABC transporter of Mycobacterium tuberculosis with implications in drug discoveryMeenakshi Balganesh, Sanjana Kuruppath, Nimi Marcel, et al.
Tuberculosis (Edinburgh, Scotland)|September 8, 2012
Evaluation of CoA biosynthesis proteins of Mycobacterium tuberculosis as potential drug targetsAnisha Ambady, Disha Awasthy, Reena Yadav, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2012
Efflux pumps of Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug candidatesMeenakshi Balganesh, Neela Dinesh, Sreevalli Sharma, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Discovery|June 1, 2012
Current possibilities and unresolved issues of drug target validation in Mycobacterium tuberculosisUmender Sharma
Drug Discovery Today|January 13, 2018
Phage-derived lysins as potential agents for eradicating biofilms and persistersUmender Sharma, Aradhana Vipra, Shankaramurthy Channabasappa
Critical Care (London, England)|May 5, 2017
Bacteriophage lysins as antibacterialsUmender Sharma, Vivek D Paul
Microbiology (Reading, England)|November 15, 2011
Alanine racemase mutants of Mycobacterium tuberculosis require D-alanine for growth and are defective for survival in macrophages and miceDisha Awasthy, Sowmya Bharath, Venkita Subbulakshmi, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2016
Antibiofilm Activity and Synergistic Inhibition of Staphylococcus aureus Biofilms by Bactericidal Protein P128 in Combination with AntibioticsSandhya Nair, Srividya Desai, Nethravathi Poonacha, et al.
Gene|August 17, 2014
Roles of the two type II NADH dehydrogenases in the survival of Mycobacterium tuberculosis in vitroDisha Awasthy, Anisha Ambady, Ashwini Narayana, et al.
Gene|December 3, 2014
Revisiting the essentiality of glutamate racemase in Mycobacterium tuberculosisSapna Morayya, Disha Awasthy, Reena Yadav, et al.
Antimicrobial Agents and Chemotherapy|October 6, 2010
Rv1218c, an ABC transporter of Mycobacterium tuberculosis with implications in drug discoveryMeenakshi Balganesh, Sanjana Kuruppath, Nimi Marcel, et al.
Tuberculosis (Edinburgh, Scotland)|September 8, 2012
Evaluation of CoA biosynthesis proteins of Mycobacterium tuberculosis as potential drug targetsAnisha Ambady, Disha Awasthy, Reena Yadav, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2012
Efflux pumps of Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug candidatesMeenakshi Balganesh, Neela Dinesh, Sreevalli Sharma, et al.
Pageof 2